CoChat

Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population

Open access
Choi, Jonggi, Han, Seungbong, Kim, Namkug, Lim, Young‐Suk · 2017 · Hepatology
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Most mortalities from liver disease and liver cancer worldwide are attributable to hepatitis B virus (HBV) and hepatitis C virus. Despite remarkable advances in the treatment of HBV over past decades, limited population‐level data are available regarding its impact on burden of liver disease and liver cancer. Mortality data from liver disease and liver cancer were obtained from the national death certificate database of Korea, an HBV‐endemic country, between 1999 and 2013, and were analyzed by Joinpoint analysis. For liver disease, number of annual deaths decreased by 62.3% (95% confidence interval [CI], 62.0‐62.6), crude death rate (CDR) decreased by 64.6% (95% CI, 64.3‐64.9) from 21.2 to 7.5 per 100,000 population, and age‐standardized death rate (ADR) declined by 75.0% (95% CI, 74.7‐75.3), between 1999 and 2013. In contrast, for liver cancer, number of annual deaths increased by 17.8% (95% CI, 17.6‐18.0) and CDR increased by 10.2% (95% CI, 10.0‐10.4) from 20.5 to 22.6, although ADR decreased by 26.9% (95% CI, 26.6‐27.2). The annual number of patients receiving oral antiviral agents against HBV increased from 1,716 to 187,226 during the study period. The increase in mean age at death from liver disease was significantly greater than that from liver cancer (8.8 vs. 6.1 years: P = 0.02). Conclusion: Marked reduction in liver disease mortality by widespread use of antiviral treatments against HBV may increase the life expectancy and number of patients at risk of developing liver cancer, inadvertently leading to increased burden of liver cancer in an HBV‐endemic population. The competing nature between death from liver disease and that from liver cancer should be carefully considered in establishing a health care policy. (H epatology 2017;66:1454–1463).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.29321

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 108

Metadata

Authors
Choi, J., Han, S., Kim, N., & Lim, Y.
Venue
Hepatology
Published
2017-10-11
Volume
66
Issue
5
Pages
1454-1463
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2639316115
Cited by
108
References
5
FWCI
9.46
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population. https://app.cochat.ai/papers/10.1002/hep.29321
The paper
Choi, J., Han, S., Kim, N., & Lim, Y. (2017). Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population. Hepatology. https://doi.org/10.1002/hep.29321

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.